Yuhan Corp Preferred (000105) - Total Assets
Based on the latest financial reports, Yuhan Corp Preferred (000105) holds total assets worth ₩3.05 Trillion KRW (≈ $2.07 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 000105 total equity for net asset value and shareholders' equity analysis.
Yuhan Corp Preferred - Total Assets Trend (2014–2024)
This chart illustrates how Yuhan Corp Preferred's total assets have evolved over time, based on quarterly financial data.
Yuhan Corp Preferred - Asset Composition Analysis
Current Asset Composition (December 2024)
Yuhan Corp Preferred's total assets of ₩3.05 Trillion consist of 46.2% current assets and 53.8% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 10.4% |
| Accounts Receivable | ₩609.13 Billion | 20.7% |
| Inventory | ₩343.16 Billion | 11.7% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩169.68 Billion | 5.8% |
| Goodwill | ₩115.07 Billion | 3.9% |
Asset Composition Trend (2014–2024)
This chart illustrates how Yuhan Corp Preferred's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 000105 company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Yuhan Corp Preferred's current assets represent 46.2% of total assets in 2024, a decrease from 52.1% in 2014.
- Cash Position: Cash and equivalents constituted 10.4% of total assets in 2024, up from 9.6% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 20.7% of total assets.
Yuhan Corp Preferred Competitors by Total Assets
Key competitors of Yuhan Corp Preferred based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Daihan Pharmaceutical Co.Ltd
KQ:023910
|
Korea | ₩344.02 Billion |
|
Aurobindo Pharma Limited
NSE:AUROPHARMA
|
India | Rs525.46 Billion |
|
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999
|
China | CN¥56.56 Billion |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538
|
China | CN¥4.75 Billion |
|
Zhejiang Xianju Pharmaceutical Co Ltd
SHE:002332
|
China | CN¥7.26 Billion |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
|
China | CN¥2.26 Billion |
|
Zhejiang Cheng Yi Pharmaceutical Co Ltd
SHG:603811
|
China | CN¥1.69 Billion |
|
Hainan Honz Pharmaceutical Co
SHE:300086
|
China | CN¥1.88 Billion |
Yuhan Corp Preferred - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.14 | 2.30 | 3.36 |
| Quick Ratio | 1.65 | 1.79 | 2.68 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩777.19 Billion | ₩739.11 Billion | ₩877.27 Billion |
Yuhan Corp Preferred - Advanced Valuation Insights
This section examines the relationship between Yuhan Corp Preferred's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.25 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 22.4% |
| Total Assets | ₩2.94 Trillion |
| Market Capitalization | $59.61 Million USD |
Valuation Analysis
Below Book Valuation: The market values Yuhan Corp Preferred's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Yuhan Corp Preferred's assets grew by 22.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Yuhan Corp Preferred (2014–2024)
The table below shows the annual total assets of Yuhan Corp Preferred from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩2.94 Trillion ≈ $1.99 Billion |
+22.43% |
| 2023-12-31 | ₩2.40 Trillion ≈ $1.63 Billion |
-2.82% |
| 2022-12-31 | ₩2.47 Trillion ≈ $1.68 Billion |
+0.36% |
| 2021-12-31 | ₩2.46 Trillion ≈ $1.67 Billion |
+2.94% |
| 2020-12-31 | ₩2.39 Trillion ≈ $1.62 Billion |
+13.05% |
| 2019-12-31 | ₩2.12 Trillion ≈ $1.43 Billion |
-2.60% |
| 2018-12-31 | ₩2.17 Trillion ≈ $1.47 Billion |
+3.78% |
| 2017-12-31 | ₩2.09 Trillion ≈ $1.42 Billion |
+2.38% |
| 2016-12-31 | ₩2.05 Trillion ≈ $1.39 Billion |
+8.81% |
| 2015-12-31 | ₩1.88 Trillion ≈ $1.27 Billion |
+16.36% |
| 2014-12-31 | ₩1.62 Trillion ≈ $1.10 Billion |
-- |
About Yuhan Corp Preferred
Yuhan Corporation manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally. It also manufactures and sells animal feed and health functional food. The company was founded in 1926 and is headquartered in Seoul, South Korea.